Please provide your email address to receive an email when new articles are posted on . Impulse Dynamics announced it received FDA and CE Mark approval and launched its miniature next-generation ...
OMAHA, Neb. (WOWT) — A man’s incredible response to a new congestive heart failure therapy at Nebraska Medicine is offering hope for others suffering from the condition. Steve Turner, 75, of Elk Horn, ...
SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...
CLEVELAND, Ohio — The Cleveland Clinic said that it implanted a dual-function cardiac device in a patient as part of a clinical trial this week, marking the first time this has been done in the world.
Heart failure is a complex clinical syndrome of symptoms and signs that happen when the heart is not working well enough, leading to reduced blood flow to body tissues. It can lead to oedema in the ...
BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...
Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Bayer AG; Bristol-Myers Squibb; Medtronic; Merck/Schering Plough; Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Edwards ...
BOSTON, Dec. 14, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo") shared the initial results of a collaborative study with the U.S. Food and Drug Administration (FDA), demonstrating the potential of ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
The evidence on cardiac contractility modulation device implantation for heart failure raises no major safety concerns. However, the evidence on efficacy is inadequate in quantity and quality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results